Compositions and methods for use in tergeting vascular destruction

The present invention is directed to compounds of Formula I: wherein X represents cis - or trans- alkenyl group represented by -(CH=CH) 1 -; each of R 1 , R 2 , R 3 and R 4 is H or Q + , while at least one of R 1 , R 2 , R 3 and R 4 is Q + ; and Q + is a sodium, piperazine, or nicotinamide cation. T...

Full description

Saved in:
Bibliographic Details
Main Authors PETTIT, GEORGE R, LIPPERT, JOHN W
Format Patent
LanguageEnglish
French
German
Published 05.10.2011
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention is directed to compounds of Formula I: wherein X represents cis - or trans- alkenyl group represented by -(CH=CH) 1 -; each of R 1 , R 2 , R 3 and R 4 is H or Q + , while at least one of R 1 , R 2 , R 3 and R 4 is Q + ; and Q + is a sodium, piperazine, or nicotinamide cation. The invention also relates to pharmaceutical compositions comprising these compounds. The compounds of the invention can be used for the treatment of neoplastic disease.
Bibliography:Application Number: EP20100075411